Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Gainers
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
- Finch Therapeutics Group (NASDAQ:FNCH) stock increased by 55.7% to $3.27 during Friday's pre-market session. The company's market cap stands at $155.5 million.
- Zymeworks (NYSE:ZYME) stock rose 47.78% to $7.33. The company's market cap stands at $423.2 million.
- Summit Therapeutics (NASDAQ:SMMT) stock moved upwards by 40.36% to $2.33. The company's market cap stands at $228.6 million.
- NuCana (NASDAQ:NCNA) stock moved upwards by 9.45% to $0.81. The company's market cap stands at $42.2 million. As per the press release, Q4 earnings came out 2 days ago.
- 4d pharma (NASDAQ:LBPS) stock increased by 9.06% to $3.85. The company's market cap stands at $86.7 million.
- Aquestive Therapeutics (NASDAQ:AQST) shares rose 8.63% to $1.51. The market value of their outstanding shares is at $62.5 million.
Losers
- Genocea Biosciences (NASDAQ:GNCA) shares declined by 43.4% to $0.23 during Friday's pre-market session. The market value of their outstanding shares is at $13.5 million.
- Accolade (NASDAQ:ACCD) shares fell 41.51% to $6.47. The market value of their outstanding shares is at $433.2 million. As per the news, the Q4 earnings report came out yesterday.
- Statera BioPharma (NASDAQ:STAB) stock fell 15.82% to $0.32. The market value of their outstanding shares is at $16.0 million.
- Aldeyra Therapeutics (NASDAQ:ALDX) stock fell 12.06% to $3.21. The company's market cap stands at $187.1 million.
- Evoke Pharma (NASDAQ:EVOK) shares declined by 11.63% to $0.44. The company's market cap stands at $14.4 million.
- Aclarion (NASDAQ:ACON) stock declined by 7.84% to $2.0. The market value of their outstanding shares is at $15.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.